SPARC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE232I01014
  • NSEID: SPARC
  • BSEID: 532872
INR
242.05
2.65 (1.11%)
BSENSE

Jun 18

BSE+NSE Vol: 64.62 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Supriya Lifesci.
SPARC
Senores Pharma.
Akums Drugs
Sudeep Pharma
Strides Pharma
P & G Health Ltd
Sanofi India
FDC
Aarti Pharma
Blue Jet Health
Why is Sun Pharma Advanced Research Company Ltd ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of -24.65% and Operating profit at -1.19% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -141.22
2
With a fall in Operating Profit of -6.73%, the company declared Very Negative results in Sep 25
  • The company has declared negative results for the last 2 consecutive quarters
  • PAT(Latest six months) At Rs -127.72 cr has Grown at -41.02%
  • NET SALES(Q) Lowest at Rs 7.86 cr
  • INTEREST(Q) Highest at Rs 7.52 cr
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -32.09%, its profits have risen by 34.6%
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -32.09% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to SPARC should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is SPARC for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
SPARC
53.88%
-0.64
50.33%
Sensex
-4.95%
0.43
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
398.73%
EBIT Growth (5y)
141.48%
EBIT to Interest (avg)
-78.63
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
0.77
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.57%
ROCE (avg)
-178.66%
ROE (avg)
58.47%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
5
Industry P/E
34
Price to Book Value
5.80
EV to EBIT
5.24
EV to EBITDA
5.21
EV to Capital Employed
4.39
EV to Sales
4.43
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
83.74%
ROE (Latest)
116.94%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

42What is working for the Company
OPERATING PROFIT TO INTEREST(Q)

The company hardly has any interest cost

NET SALES(Q)

Highest at Rs 1,853.22 cr

PBDIT(Q)

Highest at Rs 1,773.20 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 95.68%

PBT LESS OI(Q)

Highest at Rs 1,759.16 cr.

PAT(Q)

Highest at Rs 1,761.34 cr.

EPS(Q)

Highest at Rs 54.28

-10What is not working for the Company
INTEREST(Q)

Highest at Rs 11.64 cr

Loading Valuation Snapshot...
Here's what is working for SPARC
Net Sales - Quarterly
At Rs 1,853.22 cr has Grown at 13849.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 13.29 Cr
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1,759.16 cr has Grown at 2751.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs -66.35 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 1,761.34 cr has Grown at 2856.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs -63.89 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 1,853.22 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,773.20 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 95.68%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1,759.16 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 1,761.34 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 54.28
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for SPARC
Interest - Quarterly
At Rs 11.64 cr has Grown at 32.57%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Interest - Quarterly
Highest at Rs 11.64 cr
in the last five quarters and Increased by 32.57 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)